PIERIS PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q3 2024.
  • Pieris Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Pieris Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $700K, a 68.2% decline year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $2.2M, a 8.33% decline from 2022.
  • Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $2.4M, a 7.69% decline from 2021.
  • Pieris Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $2.6M, a 18.2% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $700K $0 -$500K -100% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.2M $0 -$500K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.7M $0 -$500K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.2M $700K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.2M $500K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $2.2M $500K -$100K -16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $2.3M $500K -$100K -16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $2.4M $700K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.4M $500K -$100K -16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.5M $600K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.5M $600K -$100K -14.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.6M $700K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.6M $600K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $2.6M $600K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.6M $700K +$400K +133% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $2.2M $700K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 $600K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $600K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $300K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.